Investment in US refineries is on the upswing due to increased profitability. Driven by higher oil prices, rising demand and years of underinvestment, US refining margins remain healthy. According to Wood Mackenzie, US demand for gas is forecasted to outpace supply over the next three years due, in part, to shutdowns of refineries, as upgrades […]
IMS Health reports that 2006 global pharmaceutical sales grew 7.0% to $643 billion, with “specialist-driven” products accounting for 62% of market growth. Sales in India and China increased 17.5% and 12.3% to $7.3 billion and $13.4 billion, respectively. Latin American sales grew 12.7% to $33.6 billion, and Asian-Pacific and African sales increased 10.5% to $66 […]
Routine Becomes Commonplace Although advancing technology remains an important aspect of instrument companies’ product development and reputation, companies are putting greater emphasis on instrumentation for so-called routine applications, such as quality analysis and quality control testing, or other nonresearch applications. Many of the fastest growing markets, including food and beverage and metals testing, do not […]
This month, the EPA published the “Framework for Metals Risk Assessment,” which examines the special attributes and behaviors of metals and metal compounds from the perspective of their effects on human health and the environment, and recommends strategies for future research by EPA risk assessors. As concentrations of environmental metals varies around the country, the […]
Public funding sources in the EU and Australia are establishing programs to assist biotechnology projects that are trying to negotiate the so-called “valley of death”—the funding gap that lies between academic grants and industrial licensing or venture capital backing. The European Investment Fund entered into a €8 million ($10.6 million) partnership with Belgium’s University of […]
Upcoming moves by the FDA could spur a number of pharmacogenomic studies for warfarin and eventually bring pharmacogenomic tests into the mainstream. The Food and Drug Administration is considering changes to the label of warfarin, a popular anticoagulant, that warn consumers of the drug’s varying effects on people depending on their genotypes. While there are […]
The FDA plans to define the term “gluten-free” for the purposes of food labeling. The FDA has produced a draft proposal in January and is accepting comments on the proposal until April. According to the FDA, a gluten-free food does not contain wheat, rye or barley; it also should not contain any ingredient made from […]
Major restructurings of R&D operations were announced earlier this year by two of the world’s largest pharmaceutical companies, Pfizer and Roche. Such announcements are becoming more common for so-called “big pharma” (see IBO 4/15/05, 4/15/06), as many of the world’s 10 largest drug firms struggle to maintain historical levels of profitability during a period of […]
The Environmental Protection Agency (EPA) announced regulations last week that will lower airborne pollutants over the next 25 years. Most significantly for oil refineries, the rules require that benzene levels be cut. On average, benzene made up roughly 1% of US gas in 2004. This proportion will be brought down to an average of 0.62% […]
The fiscal 2007 federal budget was finally signed into law by President Bush on February 15. The law makes permanent most of the funding amounts in the continuing resolution passed by Congress in December 2006 that essentially froze agency and program budgets at fiscal 2006 levels. However, Congress did provide funding increases for selected programs […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
